25 years ago, two strangers met in the twin towers and escaped on 9/11. What happened next?

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Financial Intelligence • Markets • World News • Independent Analysis
Published: 2026-09-07 • Permanent link

Synchronizing Global Markets: Stocks Plunge Amid AI Breakthrough Fears

Stock markets worldwide plummeted yesterday in response to the news of the AI system's breakthrough, with the Dow Jones Industrial Average plummeting 3.5% and the S&P 500 shedding 4.2%. Investors are growing increasingly uneasy about the potential implications of an AI capable of developing groundbreaking drug candidates, with many fearing a disruption to the pharmaceutical industry. Notably, shares of major pharmaceutical companies such as Pfizer and Merck plummeted 10% and 12% respectively.

Ripples of Fear: Rare Lung Condition Patients to Benefit

The AI system's breakthrough has sent shockwaves through the medical community, with experts predicting a significant improvement in the treatment of rare lung conditions such as pulmonary fibrosis. Patients who have been waiting years for a breakthrough in treatment are now being offered hope, with many expressing gratitude to the researchers at Stanford University. The AI system's ability to develop a groundbreaking drug candidate is expected to have a profound impact on the lives of these patients.

The development of AI systems capable of developing groundbreaking drug candidates is not a new phenomenon. In the 1950s, the first AI systems were developed, which were capable of solving complex mathematical problems. However, it wasn't until the 1980s that the first AI systems were developed that were capable of developing drug candidates. The current breakthrough is a significant improvement on these early systems, with the AI system being able to develop a drug candidate in a matter of weeks, rather than years.

A New Era of Collaboration: Risks and Opportunities Ahead

As the AI system continues to develop, it is likely that we will see a new era of collaboration between researchers, pharmaceutical companies, and government agencies. The potential risks of this collaboration are significant, including the potential for the AI system to be used for malicious purposes. However, the opportunities are also significant, with the potential for the AI system to revolutionize the treatment of rare lung conditions and other diseases.